L. Clément-Filliatre

Del17p without TP53 mutation confers poor prognosis in intensively treated newly diagnosed multiple myeloma patients.

M. Mohty, P. Moreau, S. Minvielle, 2020, Blood.

Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome

R. Siebert, P. Gaulard, R. De Wind, 2022, Haematologica.

Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial

N. Munshi, P. Richardson, O. Decaux, 2020 .

Improved survival in multiple myeloma during the 2005–2009 and 2010–2014 periods

M. Mohty, P. Moreau, H. Avet-Loiseau, 2021, Leukemia.

MONOMORPHIC EPITHELIOTROPIC INTESTINAL T‐CELL LYMPHOMA (MEITL): CLINICO‐PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT

P. Gaulard, L. Xerri, M. Copin, 2021, Hematological Oncology.

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study

X. Leleu, K. Laribi, V. Richez, 2023, Annals of Hematology.

Real-Life-Setting Effectiveness of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma: The Remix Study

N. Texier, M. Macro, X. Leleu, 2020 .